🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the trial is to investigate the biosimilarity of C...
Status
Completed
Location
CRST Oy, Clinical Research Services Turku Itäinen Pitkäkatu 4 B, 3rd floor
Start Date
2017-11-27
Trial ID
NCT03614715
Treatments Being Tested
Determine patient satisfaction with the single-use autoinjector for the del...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT00915577
Treatments Being Tested
The primary objective of the study is to determine whether titration of Avo...
Status
Completed
Location
Research Site
Start Date
2010-05-05
Trial ID
NCT01119677
Treatments Being Tested
This study is a two-part trial consisting of Part A (see NCT01628393) and P...
Status
Completed
Location
Receptos Study Site 115
Start Date
2013-12-03
Trial ID
NCT02047734
Treatments Being Tested
Rationale for the Study: The purpose of this study is to characterize the ...
Status
Completed
Location
Research Site
Start Date
2011-08
Trial ID
NCT01416207
Treatments Being Tested
The primary study objective is to test the superiority of Daclizumab High Y...
Status
Completed
Location
Research Site
Start Date
2010-05
Trial ID
NCT01064401
The study aims to compare the effect of daily oral treatment of laquinimod ...
Status
Completed
Location
Teva Investigational Site 1267
Start Date
2008-04-24
Trial ID
NCT00605215
Treatments Being Tested
Biogen Idec has developed a novel process to manufacture Interferon beta-1a...
Status
Completed
Location
Research Site
Start Date
2012-01
Trial ID
NCT01500408
Impaired short term memory, attention and concentration lapses, and slower ...
Status
Terminated
Location
University of Southern California
Start Date
2006-09
Trial ID
NCT00398528
Treatments Being Tested
The study was to evaluate the efficacy and safety of evobrutinib administer...
Status
Terminated
Location
Please Contact U.S. Medical Information
Start Date
2019-09-10
Trial ID
NCT04032171
Treatments Being Tested